W. L. Whitter

发表

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists.

B. E. Evans, D. Veber, K. Rittle, 1988, Journal of medicinal chemistry.

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists.

B. E. Evans, D. Veber, K. Rittle, 1988, Journal of Medicinal Chemistry.

Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.

B. E. Evans, D. Veber, K. Rittle, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260.

B. E. Evans, K. Rittle, M. Bock, 1989, Journal of medicinal chemistry.

Design of cholecystokinin peptidomimetics

B. E. Evans, D. Veber, K. Rittle, 1992 .

Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural product.

M. Bock, W. L. Whitter, G. F. Lundell, 1992, Journal of medicinal chemistry.

Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potency.

B. E. Evans, K. Rittle, M. Bock, 1988, Journal of medicinal chemistry.

Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists.

B. E. Evans, D. Veber, K. Rittle, 1987, Journal of medicinal chemistry.

Radiation sensitization and chemical studies on isoindole-4,7-diones.

W. L. Whitter, M. Ahmad, P. Neta, 1982, Radiation research.

A new amine resolution method and its application to 3-aminobenzodiazepines

B. E. Evans, D. Veber, K. Rittle, 1987 .

A New Amine Resolution Method and Its Application to 3‐Aminobenzodiazepines.

B. E. Evans, D. Veber, K. Rittle, 1987 .

Synthesis of 2H-isoindole-4,7-diones by 1,3-dipolar addition of oxazolium 5-oxides to 1,4-quinones

W. L. Whitter, J. A. Myers, J. Lanier, 1980 .

Large-scale synthesis of a cyclic hexapeptide analog of somatostatin

D. Veber, R. Freidinger, W. L. Whitter, 1987 .

Development of 1,4-benzodiazepine cholecystokinin type B antagonists.

B. E. Evans, K. Rittle, M. Bock, 1993, Journal of medicinal chemistry.

Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadom.

B. E. Evans, D. Veber, K. Rittle, 1990, Journal of medicinal chemistry.

Novel glutamic acid derived cholecystokinin receptor ligands.

R. Freidinger, W. L. Whitter, R. Chang, 1990, Journal of medicinal chemistry.

Novel oxytocin antagonists

B. E. Evans, D. Veber, M. Bock, 1993 .

Potent and Selective Oxytocin Antagonists Obtained by Chemical Modification of a Streptomyces Silvensis Derived Cyclic Hexapeptide and by Total Synthesis

D. Veber, M. Bock, R. M. Dipardo, 1990 .

Synthesis of new peptides based on models of receptor-bound conformation.

D. Veber, R. Freidinger, W. L. Whitter, 1987, Psychopharmacology series.